{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity", "item": "https://www.patentleaderboard.com/patent/8911730"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity

Methods of using antibodies to block human thymic stromal lymphopoietin (TSLP) receptor activity

US Patent 8911730 · Granted Dec 16, 2014

Estimated economic value: $577,867,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating tissue fibrosis with interleukin 242025
Combination therapy using an IL-20 antagonist and an immune checkpoint inhibitor2023
Use of IL-20 antagonists for treating eye diseases2022
Use of IL-20 antagonists for treating pancreatic cancer2018
Antibodies which specifically bind to canine vascular endothelial growth factor 2017
Method of inhibiting adipogenesis with an IL-20 antibody2017
Humanized anti-IL-20 antibody and uses thereof2017
Use of IL-20 antagonists for alleviating spinal cord injury2016
Treatment of inflammatory pain using IL-20 antagonists2016
Use of IL-20 antagonists for treating liver diseases2016
Treatment of osteoarthritis using IL-20 antagonists2015
Humanized anti-IL-20 antibody and uses thereof2015